Certara Services Archives

Publication

Apixaban for treatment of venous thromboembolism (VTEtx): Use of MBMA to support Phase 3 dose selection and beyond

Apixaban is an orally available, direct, selective inhibitor of the coagulation factor Xa that reversibly…

Jieun Choe2018 年 6 月 2 日

Publication

Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor

Danielle Pillsbury2018 年 2 月 15 日

White Paper

药物资产评估：提高交易的 "成功概率”

Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…

Danielle Pillsbury2017 年 8 月 24 日

White Paper

基于模型的荟萃分析（MBMA）：创新方法的时代来临了

MBMA integrates internal and external drug development data to inform proprietary commercial and R&D decisions.…

Danielle Pillsbury2016 年 7 月 14 日

Publication

Short-term Efficacy Reliably Predicts Long-term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model-based Meta-analysis

The objective of this study was to assess the relationship between short-term and long-term treatment…

Danielle Pillsbury2016 年 7 月 1 日

Publication

Does Age Affect Gastric Emptying Time? A Model-based Meta-analysis

Gastric emptying (GE) is often reported to be slower and more irregular in premature neonates than…

Danielle Pillsbury2015 年 5 月 1 日

Publication

A Model-based Dose-response Meta-analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma

PURPOSE: To characterize dose and response for intraocular pressure (IOP) reduction and incidence of hyperemia…

Danielle Pillsbury2015 年 5 月 1 日

Publication

Time Course of Bone Mineral Density Changes with Denosumab Compared with Other Drugs in Postmenopausal Osteoporosis: A Dose-response-based Meta-analysis

Our objective was to compare the time course of bone mineral density (BMD) changes at…

Danielle Pillsbury2014 年 10 月 1 日

Publication

Model-based Meta-analysis for Quantifying Paclitaxel Dose Response in Cancer Patients

Model-based meta-analysis of dose response is a sophisticated method to guide dose and regimen selection.…

Danielle Pillsbury2014 年 5 月 21 日

Publication

A Model-based Meta-analysis to Compare Efficacy and Tolerability of Tramadol and Tapentadol for the Treatment of Chronic Non-malignant Pain

Pain is a major symptom in many medical conditions which can be relieved thanks to…

Danielle Pillsbury2014 年 2 月 13 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Certara 服务

Apixaban for treatment of venous thromboembolism (VTEtx): Use of MBMA to support Phase 3 dose selection and beyond

Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor

药物资产评估：提高交易的 "成功概率”

基于模型的荟萃分析（MBMA）：创新方法的时代来临了

Short-term Efficacy Reliably Predicts Long-term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model-based Meta-analysis

Does Age Affect Gastric Emptying Time? A Model-based Meta-analysis

A Model-based Dose-response Meta-analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma

Time Course of Bone Mineral Density Changes with Denosumab Compared with Other Drugs in Postmenopausal Osteoporosis: A Dose-response-based Meta-analysis

Model-based Meta-analysis for Quantifying Paclitaxel Dose Response in Cancer Patients

A Model-based Meta-analysis to Compare Efficacy and Tolerability of Tramadol and Tapentadol for the Treatment of Chronic Non-malignant Pain

订阅时事通讯

快捷链接

解决方案

联系我们